Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

3 Biotech Stocks With Big News Coming in NASH
Motley Fool
Sat, 07/14/18 - 01:11 pm
Tags:
NASH, Viking Therapeutics, Gilead Sciences, Intercept Pharma, VK2809, Ocalivia, selonsertib
Pharmas call off price hikes after California law forces new warnings: report
Fierce Pharma
Wed, 07/11/18 - 11:15 pm
Tags:
drug pricing, California, Novo Nordisk, Roche, Novartis, Gilead Sciences
Gilead’s Kite taps Eisai cancer vet Amoroso to lead the charge for CAR-T sales
Fierce Pharma
Tue, 07/10/18 - 11:29 am
Tags:
Gilead Sciences, CAR-T, Eisai
Jefferies says Gilead is poised for turnaround—and JAK inhibitor could be key
Fierce Biotech
Thu, 07/5/18 - 07:42 pm
Tags:
Gilead Sciences, JAK inhibitors, filgotinib, rheumatoid arthritis
Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma
CP Wire
Fri, 06/29/18 - 09:50 am
Tags:
Kite Pharma, Gilead Sciences, EMA, CHMP, Yescarta, B-cell lymphoma
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
Yahoo/Reuters
Wed, 06/20/18 - 09:28 am
Tags:
GSK, Gilead Sciences, HIV, AIDS, Dolutegravir, lamivudine, Biktarvy
Big Biotech Set for Earnings Blowout?
Barron's
Sat, 06/16/18 - 01:24 pm
Tags:
biotech, earnings, Gilead Sciences, Alexion, Vertex Pharmaceuticals
Cash for NASH: 2 Top Biotech Takeover Targets and 3 Potential Buyers
Motley Fool
Fri, 06/15/18 - 07:04 pm
Tags:
NASH, liver disease, Viking Therapeutics, Madrigal Pharmaceuticals, Pfizer, Bristol-Myers Squibb, Gilead Sciences
Balm for Gilead: Unclean Hands Render Patents Unenforceable
JD Supra
Thu, 06/7/18 - 10:54 pm
Tags:
Merck, Gilead Sciences, patents, hepatitis C
Gilead, Hookipa pen hepatitis B, HIV research collaboration
Fierce Biotech
Wed, 06/6/18 - 09:34 am
Tags:
Gilead Sciences, Hookipa, hepatitis B, HIV, vaccines, drug development
Gilead, Galapagos hit goal in psoriatic arthritis phase 2
Fierce Biotech
Thu, 05/31/18 - 09:33 am
Tags:
Gilead Sciences, Galapagos, filgotinib, psoriatic arthritis, clinical trials, ulcerative colitis
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
Endpoints
Tue, 05/29/18 - 09:22 pm
Tags:
M&A, JNJ, Merck, Pfizer, Gilead Sciences, Amgen, Biogen, Takeda, Regeneron, Alexion
Biopharma M&A: You Ain’t Seen Nothing Yet
Barron's
Fri, 05/25/18 - 09:32 am
Tags:
JNJ, Merck, Pfizer, Gilead Sciences, Amgen, Regeneron, Alexion, M&A
Kronos Bio Appoints Former Gilead R&D Veteran as President and CEO
CP Wire
Wed, 05/23/18 - 10:26 pm
Tags:
Kronos Bio, Gilead Sciences
Gilead finds new home in Europe for CAR-T manufacturing
Biopharma Dive
Tue, 05/15/18 - 11:43 am
Tags:
Gilead Sciences, Netherlands, Yescarta, drug manufacturing
HIV Patients File Class Action and Personal Injury Lawsuits for California Patients Against Gilead
CP Wire
Wed, 05/9/18 - 09:27 am
Tags:
Gilead Sciences, HIV, patients, TDF, TAF, California
New approval sets up CAR-T showdown for Gilead, Novartis
Biopharma Dive
Wed, 05/2/18 - 10:00 pm
Tags:
Kymriah, Novartis, cell therapy, Yescarta, Gilead Sciences
Another disappointing quarter from Gilead, shares down almost 6%
GoinPharma
Wed, 05/2/18 - 07:26 pm
Tags:
Gilead Sciences, earnings
Gilead and Alphabet's Verily to Collaborate on Research in Immunological and Molecular Drivers of Inflammatory Diseases
CP Wire
Mon, 04/30/18 - 09:08 pm
Tags:
Gilead Sciences, Verily, Immunoscape, lupus, rheumatoid arthritis, inflammatory bowel disease
What to Expect With Gilead Sciences Inc.'s Q1 Earnings Results
Motley Fool
Sun, 04/29/18 - 12:11 pm
Tags:
Gilead Sciences, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.